Anxiety, Obsessive Compulsive Disorder & Anxiolytics
ANXIETY, OBSESSIVE COMPULSIVE DISORDER & ANXIOLYTICS
Dr. Asma Perveen
GSP 508 Psychopharmacology
FUNCTION OF EMOTIONS
Joy: Promotes social bonding and encourages exploration of the environment.
Sadness: Signals loss and can foster social support but may lead to withdrawal if prolonged.
Anger: Can motivate protection and change, but may lead to conflict if expressed maladaptively.
Disgust: Helps in avoiding harmful substances, and can foster social cohesion by rejecting undesirable behaviors.
Fear: Triggers fight-or-flight responses, promotes survival by avoiding danger.
DIFFERENTIAL DIAGNOSIS
Symptoms of Anxiety
Physical Symptoms:
Trembling or feeling shaky.
Restlessness and muscle tension.
Shortness of breath and smothering sensation.
Tachycardia (rapid heartbeat).
Sweating, cold hands, and feet.
Light-headedness and dizziness.
Paresthesia (tingling of the skin).
Diarrhea, frequent urination, or both.
Feelings of unreality (derealization).
Initial insomnia (difficulty falling asleep).
Impaired attention and concentration.
Nervousness, edginess, or tension.
Anxiety versus Panic Attacks
Anxiety:
Onset: Can be gradual
Duration: Prolonged
Intensity: Mild to moderate, usually precipitated by stressors.
Panic Attacks:
Onset: Very sudden
Duration: One to thirty minutes
Intensity: Severe, often without identifiable triggers.
Anxiety Syndromes
Generalized Anxiety Disorder (GAD)
Adjustment Disorder with Anxiety
Specific Phobias
Social Phobias/Social Anxiety Disorder
Agoraphobia without Panic
Anxiety Symptoms Secondary to General Medical Conditions
Substance-Induced Anxiety Disorder
“Neurotic” Anxiety
Panic Disorder
Generalized Anxiety Disorder (GAD)
Chronic, low-level anxiety without specific stressors.
Excessive worry about multiple aspects of life.
Adjustment Disorder with Anxiety
Symptoms arise after identifiable stressors.
Acute onset following stressor exposure.
Specific Phobias
Intense fear of specific objects or situations.
Symptoms manifest only in phobic situations.
Complete avoidance of phobic triggers.
Social Anxiety Disorder
Anxiety only in social/interpersonal contexts, fear of judgment and rejection.
Avoidance impacts work and personal functioning.
Agoraphobia Without Panic
Intense fear of situations where escape is difficult or embarrassing.
Commonly develops during Panic Disorder, but no previous panic attacks experienced.
Anxiety Related to Medical Conditions/Substance Use
Anxiety symptoms secondary to other medical conditions or substance abuse.
Neurotic Anxiety
Conflicts exist at unconscious or conscious levels.
Symptoms manifest overtly as generalized anxiety.
Panic Disorder
Characterized by recurring unprovoked panic attacks, anticipatory anxiety develops over time, commonly associates with agoraphobia.
Etiology of Anxiety Disorders
Psychogenic Origins
Psychoanalytic Theory (Freud):
Anxieties arise from unconscious danger perception—realistic, moral, and id anxiety.
Defensive operations trigger symptoms when defenses fail.
Cognitive Models (Beck, 1976):
Misjudging dangers; distorted perceptions lead to inappropriate fight-or-flight responses.
Biological Factors
Involves complex neural pathways, hormonal responses, and neurotransmitter networks.
The body mobilizes resources to cope with perceived danger; hyperarousal states develop.
Neural Pathways
Fight-or-Flight Response:
Triggered by stressful events involving the amygdala, hypothalamus, and sympathetic nervous system leading to adrenaline and cortisol release.
Neuroendocrine Pathways: High arousal leads to increased respiration, alertness, and control of physiological states via CRF and TRH feedback loops.
Treatment Approaches for Anxiety Disorders
General Anxiety Treatments
Psychotherapy: Typically first-line treatment.
Medications: Can be indicated for severe cases.
Benzodiazepines: Quick-acting but carry risks of addiction and tolerance.
Buspirone: Non-addictive, slower onset but effective.
SSRIs/SNRIs: Increasingly used for chronic anxiety.
Gabapentin: Non-habit forming, often used for bipolar anxiety.
Specific Treatment Recommendations
Panic Disorder
Combined pharmacological and psychological interventions are most effective.
Medications aimed at reducing panic attacks include benzodiazepines and antidepressants.
Agoraphobia Without Panic
Treated with behavioral therapy, relaxation training, and possible acute medications.
Social Phobias
Primarily treated through cognitive behavioral therapy; medications used if symptoms are pervasive.
OBSESSIVE-COMPULSIVE DISORDER (OCD)
Definitions
Obsessions: Persistent, intrusive thoughts recognized as senseless—often concerning contamination, aggression, religion, or symmetry.
Compulsions: Repetitive behaviors or rituals responding to obsessions (e.g., checking behaviors, cleaning, counting).
DSM-5 OCD Disorders
Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania, and others.
Increased risk of co-occurring Major Depression and substance use disorders.
Etiology of OCD
Traditional theories related to early strict parenting but biological processes show a stronger correlation.
Genetic factors shown to be present; higher incidence in first-degree relatives.
Neuroimaging reveals increased metabolic activity in relevant brain regions for symptomatic patients.
Treatment for OCD
Psychotherapy
Behavioral techniques such as exposure and response prevention show high success rates.
Medication Treatment
SSRIs are most effective, typically requiring higher doses than for depression.
Nesting rituals reflect instincts similar to primitive behaviors, reinforcing compulsiveness.
Summary of Medication Classifications
Benzodiazepines: alprazolam, diazepam used for anxiety and panic disorders.
Azapirones: buspirone for generalized anxiety.
SSRIs: fluoxetine, paroxetine for OCD and anxiety.
Beta Blockers: propranolol for performance anxiety symptoms.
Anti-histamines: hyroxyzine used for anxiety.
ANXIOLYTICS
Mechanisms and Risks
Benzodiazepines work mainly by enhancing GABA functions within the CNS.
Side Effects: Sedation, dependency, overdose risks especially in individuals with prior substance use issues.
Withdrawal Management
Gradual tapering advised to minimize withdrawal symptoms; rapid discontinuation can lead to severe effects.
Patient Education
Importance of discussing risks, benefits, and treatment duration to avoid dependence.
Summary of Treatment Recommendations
For Depression: SSRIs/SNRIs.
For Anxiety Disorders: Benzodiazepines for short-term; SSRIs/SNRIs for long-term.
For OCD: High-dose SSRIs or tricyclics.
For PTSD: SSRIs used effectively.
For Performance Anxiety: Beta-blockers recommended.
Chronic Conditions: Medications with long-term management strategies are needed.